DALLAS, May 7, 2020 /PRNewswire/ -- Jacobs (NYSE:J) is pleased to announce that Nino Kharaishvili, MD, MBA, PMP, CMAP, a global expert in health security and health system emergency preparedness and resilience, has joined the company's Federal & Environmental Solutions team as Principal of the Health System Resilience practice.
The practice combines Jacobs' multidisciplinary expertise in policy development, legislation and planning for emergency preparedness, response and recovery; broader organizational/inter-agency coordination; comprehensive healthcare infrastructure services; logistics and supply chain management; operational management and business continuity; information management systems and data analysis; and assessments of risks, vulnerabilities and technical capacities, as well as training and exercises for healthcare workers, teams and support staff.
Dr. Kharaishvili brings to Jacobs more than 15 years of healthcare systems consulting experience supporting the U.S. Department of Defense, and most recently the Defense Threat Reduction Agency's (DTRA) Biological Threat Reduction Program (BTRP), which focuses on especially dangerous pathogen and infectious disease surveillance, biosafety and biosecurity. She has specific expertise in defining pathways for healthcare system sustainability and resilience, as well as designing and implementing various emergency management exercises aimed at improving public health emergency preparedness and response.
"Jacobs recognizes that the challenges we face today with the COVID-19 pandemic, and those we anticipate in the future, require more resilient, holistic solutions to improve public health," said Jacobs Federal & Environmental Solutions Senior Vice President and General Manager Tim Byers. "Dr. Kharaishvili strengthens our already impressive healthcare services team and brings a new depth of health security expertise, a broad-based understanding of emergency management, and a global consulting portfolio that will be a tremendous asset in leading our Health System Resilience practice."
As part of her DTRA work, Dr. Kharaishvili developed a risk assessment tool that analyzes a country's vulnerability to naturally-occurring, accidental or nefarious release of weaponizable infectious pathogens. The tool has been used in more than 25 countries to establish a baseline of the health security risk landscape and to provide a foundation for identifying and prioritizing system-wide risk mitigation and management activities.
Additionally, Dr. Kharaishvili developed and implemented a Global Health Security Capacity and Capability Measurement Framework. The framework, which has helped transform BTRP's business practices, tracks impacts across 24 programmatic biosafety, biosecurity and biosurveillance metrics, as well as numerous capability, capacity, sustainability and regional indicators for human and animal health systems.
Dr. Kharaishvili received her doctor of medicine degree from Aiety Medical School, Georgia (country), and her Master of Business Administration from the College of Saint Rose, Albany, New York. She also provides academic and technical support to the National Center for Disaster Medicine and Public Health at the Uniformed Services University, within the scope of its mission leading domestic and international disaster health education and research efforts.
At Jacobs, we're challenging today to reinvent tomorrow by solving the world's most critical problems for thriving cities, resilient environments, mission-critical outcomes, operational advancement, scientific discovery and cutting-edge manufacturing, turning abstract ideas into realities that transform the world for good. With $13 billion in revenue and a talent force of more than 55,000, Jacobs provides a full spectrum of professional services including consulting, technical, scientific and project delivery for the government and private sector. Visit jacobs.com and connect with Jacobs on Facebook, Instagram, LinkedIn and Twitter.
Certain statements contained in this press release constitute forward-looking statements as such term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and such statements are intended to be covered by the safe harbor provided by the same. Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management's current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements, including, but not limited to, the impact of the COVID-19 pandemic and the related reaction of governments on global and regional market conditions and the company's business. For a description of some additional factors that may occur that could cause actual results to differ from our forward-looking statements, see our Annual Report on Form 10-K for the year ended September 27, 2019, and in particular the discussions contained under Item 1 - Business; Item 1A - Risk Factors; Item 3 - Legal Proceedings; and Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations, as well as the company's other filings with the Securities and Exchange Commission. The company is not under any duty to update any of the forward-looking statements after the date of this press release to conform to actual results, except as required by applicable law.
For press/media inquiries: